UB Paderborn / Katalog / Suche / in CDI

Philosophical transactions of the Royal Society of London. Series A: Mathematical, physical, and engineering sciences, 2017-11, Vol.375 (2107), p.20170180-20170180

2017

Link zum Volltext

Verfügbarkeit prüfen

Moving Away from Chaos: Intentional and Adaptive Management of the Non-visit Care River

Journal of general internal medicine : JGIM, 2023-02, Vol.38 (3), p.784-788

2023

Link zum Volltext

Verfügbarkeit prüfen

Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

Clinical cancer research, 2021-03, Vol.27 (5), p.1463-1475

2021

Link zum Volltext

Verfügbarkeit prüfen

Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. Reply

The New England journal of medicine, 2019-02, Vol.380 (9), p.889-890

2019

Link zum Volltext

Verfügbarkeit prüfen

Drugs in development for small cell lung cancer

Journal of thoracic disease, 2020-10, Vol.12 (10), p.6298-6307

2020

Link zum Volltext

Verfügbarkeit prüfen

High levels of expression of Trop-2 in thymic epithelial tumors

Lung cancer (Amsterdam, Netherlands), 2023-10, Vol.184, p.107324-107324, Article 107324

2023

Link zum Volltext

Verfügbarkeit prüfen

The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors

Clinical lung cancer, 2020-11, Vol.21 (6), p.e539-e543

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 12.814

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11.371)
Mit Volltextzugriff
(11.923)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(8.407)
Life Sciences & Biomedicine
(5.546)
Humans
(4.042)
Female
(1.939)
Male
(1.856)
Animals
(1.782)
Physical Sciences
(1.730)
Technology
(1.512)
Biological And Medical Sciences
(1.077)
Mice
(982)
Science & Technology - Other Topics
(967)
Middle Aged
(955)
Adult
(919)
Chemistry
(861)
Oncology
(797)
Biochemistry & Molecular Biology
(787)
Medical Sciences
(778)
Aged
(754)
Multidisciplinary Sciences
(708)
Engineering
(659)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(6.428)
MEDLINE
(5.434)
IngentaConnect
(4.903)
Journals@Ovid Full Text
(3.208)
NUS Single-Journal Subscriptions
(3.089)
Elsevier ScienceDirect Journals Complete
(2.218)
IngentaConnect Journals
(2.123)
Wiley Blackwell Single Titles
(1.474)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.417)
Wiley Online Library
(948)
SpringerLink (Online service)
(863)
Nature - Journals : Nature ; Nature Climate Change
(772)
IEEE/IET Electronic Library (IEL)
(563)
JSTOR
(469)
Access via Oxford University Press
(455)
Nexis
(373)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(361)
Oxford Journals 2020 Medicine
(334)
Ebook Central Perpetual and DDA
(327)
eBooks on EBSCOhost
(301)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(243)
Cancer Research
(227)
Journal Of Clinical Oncology
(193)
Plos One
(187)
Proceedings Of The National Academy Of Sciences - Pnas
(157)
Nature Communications
(154)
The Journal Of Biological Chemistry
(133)
Journal Of The American Chemical Society
(123)
Scientific Reports
(111)
Nature
(103)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

Refining the treatment of NSCLC according to histological and molecular subtypes

NRG1 fusions: Biology to therapy

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Drugging KRAS: current perspectives and state-of-art review

Plain language summary of NRG1 fusions in cancer: current knowledge and treatment with afatinib and other drugs

Effect of grain size on the resistance to hydrogen embrittlement of API 2W Grade 60 steels using in situ slow-strain-rate testing

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Evolving role of immunotherapy in small cell lung cancer

A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer

Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus

Moving Away from Chaos: Intentional and Adaptive Management of the Non-visit Care River

Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. Reply

Drugs in development for small cell lung cancer

High levels of expression of Trop-2 in thymic epithelial tumors

The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors

Suchergebnisse filtern